Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Pulse Biosciences, Inc. (PLSE) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "PULSE BIOSCIENCES, INC. Condensed Consolidated Balance Sheets June 30, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 58,747 $ 61,139 Prepaid expenses and other current assets 1,211 1,008 Total current assets 59,958 62,147 Property and equipment, net 1,755 1,961 Intangible assets, net 2,218 2,551 Goodwill 2,791 2,791 Right-of-use assets 7,670 8,062 Other assets 365 365 Total assets $ 74,757 $ 77,877 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 1,794 $ 1,573 Accrued expenses 2,844 2,595 Lease liability, current 975 896 Related party note payable, current — 917 Total current liabilities 5,613 5,981 Lease liability, less current 8,644 9,144 Related party note payable, less current — 65,000 Total liabilities 14,257 80,125 Stockholders..."
05/11/2023 8-K Quarterly results
Docs: "PULSE BIOSCIENCES, INC. Condensed Consolidated Balance Sheets March 31, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 54,098 $ 61,139 Prepaid expenses and other current assets 849 1,008 Total current assets 54,947 62,147 Property and equipment, net 1,865 1,961 Intangible assets, net 2,384 2,551 Goodwill 2,791 2,791 Right-of-use assets 7,869 8,062 Other assets 365 365 Total assets $ 70,221 $ 77,877 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,160 $ 1,573 Accrued expenses 3,091 2,595 Deferred revenue 4 — Lease liability, current 935 896 Related party note payable, current 801 917 Total current liabilities 6,991 5,981 Lease liability, less current 8,898 9,144 Related party note payable, current 65,000 65,000 Total liabilities 80,8..."
11/10/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/31/2022 8-K Quarterly results
Docs: "Webcast and Conference Call Information Pulse Biosciences’ management will host a conference call today, March 31, 2022, beginning at 1:30pm PT. Investors interested in listening to the conference call may do so by dialing 1-877-705-6003 for domestic callers or 1-201-493-6725 for international callers. A live and recorded webcast of the event will be available at https://investors.pulsebiosciences.com/. ® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The CellFX® System is the first commercial..."
05/10/2021 8-K Quarterly results
02/22/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to Pulse Biosciences’ expectations regarding regulatory clearance and the timing of FDA and other regulatory filings or approvals, including meetings with FDA and the ability of the Company to successfully complete a 510 submission for the CellFX System, the ability of the Company to prepare and provide data to FDA and the notified body responsible for conducting CE mark review, the ability of the Company to obtain a CE mark or Health Canada approval for the CellFX System, NPS technology including the effectiveness of such technology and the effectiveness of related clinical studies in predicting outcomes resulting from t..."
08/10/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
03/16/2020 8-K Quarterly results
Docs: "Pulse Biosciences Report Fourth Quarter and Full Year 2019 Financial Results"
04/30/2019 8-K Quarterly results
Docs: "PULSE BIOSCIENCES QUARTERLY INVESTOR CONFERENCE CALL"
11/07/2017 8-K Quarterly results
Docs: "PULSE BIOSCIENCES QUARTERLY INVESTOR CONFERENCE CALL"
07/27/2017 8-K Quarterly results
Docs: "PULSE BIOSCIENCES QUARTERLY INVESTOR AND ANALYST CONFERENCE CALL"
05/04/2017 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy